275 related articles for article (PubMed ID: 25215458)
1. Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review.
Singh VK; Newman VL; Seed TM
Cytokine; 2015 Jan; 71(1):22-37. PubMed ID: 25215458
[TBL] [Abstract][Full Text] [Related]
2. An update on sargramostim for treatment of acute radiation syndrome.
Singh VK; Seed TM
Drugs Today (Barc); 2018 Nov; 54(11):679-693. PubMed ID: 30539167
[TBL] [Abstract][Full Text] [Related]
3. PEGylated G-CSF (BBT-015), GM-CSF (BBT-007), and IL-11 (BBT-059) analogs enhance survival and hematopoietic cell recovery in a mouse model of the hematopoietic syndrome of the acute radiation syndrome.
Plett PA; Chua HL; Sampson CH; Katz BP; Fam CM; Anderson LJ; Cox GN; Orschell CM
Health Phys; 2014 Jan; 106(1):7-20. PubMed ID: 24276546
[TBL] [Abstract][Full Text] [Related]
4. Biologics as countermeasures for acute radiation syndrome: where are we now?
Singh VK; Romaine PL; Newman VL
Expert Opin Biol Ther; 2015 Apr; 15(4):465-71. PubMed ID: 25416452
[TBL] [Abstract][Full Text] [Related]
5. Overview of use of G-CSF and GM-CSF in the treatment of acute radiation injury.
Reeves G
Health Phys; 2014 Jun; 106(6):699-703. PubMed ID: 24776902
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
Tanikawa S; Nakao I; Tsuneoka K; Nara N
Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
8. Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivors.
Chua HL; Plett PA; Sampson CH; Katz BP; Carnathan GW; MacVittie TJ; Lenden K; Orschell CM
Health Phys; 2014 Jan; 106(1):21-38. PubMed ID: 24276547
[TBL] [Abstract][Full Text] [Related]
9. Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents.
Singh VK; Romaine PL; Newman VL; Seed TM
Expert Opin Ther Pat; 2016 Dec; 26(12):1399-1408. PubMed ID: 27610458
[TBL] [Abstract][Full Text] [Related]
10. Sargramostim in acute radiation syndrome.
Lazarus HM; McManus J; Gale RP
Expert Opin Biol Ther; 2022 Nov; 22(11):1345-1352. PubMed ID: 36325797
[TBL] [Abstract][Full Text] [Related]
11. PEG-G-CSF and L-Citrulline Combination Therapy for Mitigating Skin Wound Combined Radiation Injury in a Mouse Model.
Wang L; Zhai M; Lin B; Cui W; Hull L; Li X; Anderson MN; Smith JT; Umali MV; Jiang S; Kiang JG; Xiao M
Radiat Res; 2021 Jul; 196(1):113-127. PubMed ID: 33914884
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
13. A wearable gamma radiation-responsive granulocyte colony-stimulating factor microneedle system protecting against ionizing radiation-induced injury.
Yu X; Zhu L; Liang X; Yuan B; Li M; Hu S; Ding P; Du L; Guo J; Jin Y
Acta Biomater; 2022 Jul; 146():197-210. PubMed ID: 35487423
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
15. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia.
Patchen ML; Fischer R; MacVittie TJ
Exp Hematol; 1993 Feb; 21(2):338-44. PubMed ID: 7678816
[TBL] [Abstract][Full Text] [Related]
16. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor in the treatment of acute radiation syndrome: a concise review.
Hofer M; Pospíšil M; Komůrková D; Hoferová Z
Molecules; 2014 Apr; 19(4):4770-8. PubMed ID: 24743934
[TBL] [Abstract][Full Text] [Related]
18. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor.
Broxmeyer HE; Benninger L; Patel SR; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1994 Jan; 22(1):100-2. PubMed ID: 7506671
[TBL] [Abstract][Full Text] [Related]
19. Haematopoietic growth factors as supportive therapy in HIV-infected patients.
Hermans P
AIDS; 1995 Dec; 9 Suppl 2():S9-S14. PubMed ID: 8775801
[TBL] [Abstract][Full Text] [Related]
20. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
Meng FY; Xu B; Sun J; Yang Y; Niu JN
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
